Navigation Links
Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results
Date:8/5/2008

LEXINGTON, Mass., Aug. 5 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced its consolidated results of operations for the third quarter ended June 30, 2008. The Company will host a conference call and webcast today beginning at 9:00 am eastern time (details follow below).

The Company reported revenues of $20.4 million and a consolidated net loss of $19.0 million or $0.25 per share for the quarter ended June 30, 2008. This compares to revenues of $12.2 million and a consolidated net loss of $72.3 million or $1.02 per share for the quarter ended June 30, 2007. During the quarter ended June 30, 2008, the Company reported a restructuring charge of approximately $3.5 million. During the quarter ended June 30, 2007, the Company incurred one time charges of $53.3 million related to the acquisition of Valera Pharmaceuticals which was completed on April 18, 2007.

For the nine months ended June 30, 2008, the Company reported revenues of $54.5 million and a consolidated net loss of $51.6 million or $0.67 per share compared to revenues of $36.6 million and a consolidated net loss of $95.1 million or $1.56 per share for the nine months ended June 30, 2007.

At June 30, 2008, the Company had consolidated cash and cash equivalents totaling approximately $52.6 million.

"This has been a very active and eventful quarter for the Company," said Glenn L. Cooper, chairman and chief executive officer of Indevus. "Obviously, we are very disappointed in the FDA's decision to issue an approvable letter for NEBIDO(R). This certainly was not the decision we were expecting. We stand by the safety and efficacy of NEBIDO, which is the market leader in many countries around the world for testosterone therap
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Indevus Pharmaceuticals to Present at Upcoming Investor Conferences
2. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
3. Indevus Pharmaceuticals To Present at RBC Capital Markets Conference
4. Indevus To Announce First Quarter Fiscal 2008 Financial Results On Thursday, February 7, 2008
5. Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
6. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
7. Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
10. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
11. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... CareSource, ... and Corporate Communications. In this capacity, Michael will provide strategic leadership for CareSource’s ... leader in consumer-focused programs that have contributed to the company’s rapid growth. As ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... In an ... from the Plastic and Reconstructive Surgery Global Open Journal that discusses the future of ... article discussed how, in the future, customized implants, prosthetics, and other 3-D printed tools ...
(Date:8/31/2015)... ... , ... NJ Top Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and ... Michael Betsy graduated from Don Bosco Prep in 1990 and was Class Salutatorian. He ... sports in his senior year. He was inducted into the National Honor Society as ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... According ... of the University of Sweden showed that most adolescents who underwent bariatric surgery “felt ... average, the 88 adolescent bariatric patients who participated in the study felt that their ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad Phil, son Scott, ... on Aug. 26, generously hosted by the Collinsville Chamber of Commerce, but the ... Call Center and website since Aug. 17. , The Greens have operated Green ...
Breaking Medicine News(10 mins):Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2
... those trying to lose weight, there is a lot of confusion ... now is // to eat a low carbohydrate diet, a new ... weight loss -- even when the amount of food is not ... 12-week low fat, high-carb diet alone and in combination with exercise. ...
... have Parkinson’s disease. It is a neurological condition // that ... therapy can improve both of these problems. A pulse of ... movement. This is done inorder to improve stiffness in patients. ... magnetic stimulation. ,For nearly 15 years, Criner has dealt ...
... shows the reason some adolescents experience depression could be ... to have a smaller hippocampus -- the part of ... ,Researchers sampled nearly 30 adolescents between ages 13 ... major depressive disorder.Magnetic resonance imaging was performed to measure ...
... most common type of plastic surgery performed for cosmetic ... 269,000 procedures were performed. ,Researchers examined data from ... the mammogram results of women with breast implants to ... of the study show breast implants decreased the sensitivity ...
... who suffer from migraine headaches may be at risk for ... brain where the tissue has died. ,Researchers studied ... grouped the patients into categories of having migraines with visual ... group was also included in the study. Participants had a ...
... bacterial infection that affects the gums and bones supporting ... can not only reveal the general health of patients ... ,Researchers from Japan studied more than 7,450 men and ... 37 items, including cholesterol and C-reactive protein, which are ...
Cached Medicine News:
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced ... the United States and Canada ... test. The deal, worth up to $8.5 million over the ... the clinical validation and regulatory approval of Daktari,s HCV test. ... a point-of-care instrument that can detect low levels of virus ...
(Date:8/31/2015)... August 31, 2015 A ... global cardiovascular monitoring and diagnostic devices market stood ... to reach a value of approximately US$7.0 billion ... between 2013 and 2019. The title of the ... (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, ...
(Date:8/31/2015)... -- On August 5, 2015, the U.S. District Court for ... motions to dismiss securities class action claims against Galena ... its directors. The class actions allege that the individual ... artificially inflate Galena,s stock price, and during an eighteen ... sold massive amounts of their personally-held shares. ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2
... viscoelastic insert runs alongside the Achilles ... and targeted intermittent compression during movement. ... irritation of the Achilles tendon is ... wedge (raises heel about 6 mm). ...
... II is effective for acute, rehabilitation, ... to help prevent injury and reinjury ... exceptional support for medial and lateral ... plantar flexion. Unique split-pad system includes ...
Softsplint after bunion surgery. Hook-and-loop closure. Maintains hallux positioning and metatarsophalangeal alignment. Washable....
... Pediatric Ankle Cryo/Cuff is specifically designed to ... Using a combination of controlled compression and ... pain. The Pediatric Ankle Cryo/Cuff is ideal ... episodes in hemophilia.,The Pediatric Ankle Cryo/Cuff is ...
Medicine Products: